Delivery Order SPE2DB22D9367-SPE2DB23FSZ53
Award Date 8/3/23
Potential Completion Date 8/24/23
Potential Value $51K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,891.36 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from July 10, 2023 through July 31, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for supplies and services to fulfill military operations. This delivery order provides cancer treatment pharmaceuticals for...
- The Defense Logistics Agency, on behalf of the Department of Defense, awarded a $14,768.58 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561695383 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from August 2, 2023 through August 23, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing logistics support and supplies in support of various DOD...
- The Defense Logistics Agency awarded a $39,456.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 4562070724 units of KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois and the period of performance is from August 30, 2023 through September 21, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts and supply chain management as one of the largest logistics combat support agencies within the federal...
- The Defense Logistics Agency awarded a $14,768.58 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561740665 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois and the period of performance is from August 4, 2023 through August 25, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for supplies and services to enable military readiness and operations. This delivery order provides cancer treatment...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-three thousand, six hundred seventy-four dollars and eight cents ($23,674.08) to DMS Pharmaceutical Group Inc. The order is for 4562154553 units of KADCYLA 160 MG VIALS to be delivered to a location in Park Ridge, Illinois. The place of performance is also in Park Ridge. The period of performance is from September 8, 2023 through September 29, 2023. No major subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $14,768.58 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562251945 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The start date is September 18, 2023 and the end date is October 10, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procurement and distribution of medical supplies and pharmaceuticals. This delivery order provides Kadcyla, a breast...
- The Defense Logistics Agency awarded a delivery order valued at twenty-three thousand, six hundred seventy-four dollars and eight cents to DMS Pharmaceutical Group Inc. for the procurement of KADCYLA 160 MG VIALS. The prime contractor will deliver the pharmaceutical products to a location in Park Ridge, Illinois by September 12, 2023 under a firm fixed price contract. The Defense Logistics Agency supports Department of Defense programs by procuring medical supplies and equipment. No set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,768.58 to DMS Pharmaceutical Group Inc. to supply 4562154554 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The order period of performance is from September 8, 2023 through September 29, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency supports Department of Defense procurement through contracts for supplies and logistical support,...
- The Defense Logistics Agency awarded a $12,307 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4561681024 KADCYLA 100 MG VIALS. The place of performance is Park Ridge, Illinois. The order period of performance is from July 28, 2023 through August 18, 2023. The Defense Logistics Agency supports military readiness by procuring, managing and providing supplies in various categories including pharmaceuticals. No set aside designation or subcontractors were indicated.
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. under an unrestricted competition for the delivery of 4562449308 KADCYLA 100 MG VIALS. The order has a potential value of fourteen thousand seven hundred sixty-eight dollars and fifty-two cents ($14,768.52) and requires completion by October 31, 2023. Performance will take place in Park Ridge, Illinois. No subcontractors or additional context were indicated. The firm fixed price order is for the delivery of...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB23FSZ53Delivery Order
The Defense Logistics Agency awarded a $51,256.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 4561727282 units of KADCYLA 160 MG VIALS. The place of performance is Park Ridge, Illinois and the period of performance is from August 3, 2023 through August 24, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the Department of Defense, this delivery order is likely providing cancer treatment drugs to military treatment facilities and their beneficiaries. No set aside designation or subcontractors are indicated.
Generated 12/22/23, 8:49 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.3k | 8/3/23 |